TY - JOUR AU - Motzer, RJ; Tannir, NM; McDermott, DF TI - Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma JO - N Engl J Med VL - 378 PY - 2018 DO - 10.1056/NEJMoa1712126 L3 - PubMed-ID: 29562145 L3 - PubMed-ID: 29562145 SP - 1277 EP - 1290 N1 - et al. ER -